transitioning to highly effective therapies for the treatment of chronic hepatitis c virus infection: a policy statement and implementation guideline. | chronic hepatitis c virus (hcv) infection increases all-cause mortality, rates of cirrhosis, hepatocellular carcinoma, liver transplantation and overall health care utilization. morbidity and mortality disproportionately affect individuals born between 1945 and 1975. the recent development of well-tolerated and highly effective therapies for chronic hcv infection represents a unique opportunity to dramatically reduce rates of hcv-related complications and their costs. critical to the introductio ... | 2014 | 25390613 |